Delivery Order SPE2DB24D9224-SPE2DB25FJGFS
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $8.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $34,490.80 to DMS Pharmaceutical Group Inc. on August 28, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a firm fixed-price arrangement and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation,...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg tablets (120-count units). This firm fixed-price delivery order is associated with DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xtandi 40 mg tablets (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply to support Department of Defense healthcare requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This delivery order was issued without a set-aside designation and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 8, 2025, for 60 tablets of Xtandi 80 mg, an oncology medication. The delivery order is a firm fixed-price contract with a completion date of September 9, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL...
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,508.77 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (quantity 60). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed in Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis within the...
- On August 22, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $23,366.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4569186045, calls for the supply of 60 tablets of Xtandi 80 mg, an oncology medication used in the treatment of prostate cancer. This award represents a single delivery order issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count packaging). This firm fixed-price delivery order, valued at $4,169.59, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the drug Xtandi 80 mg tablets and has an ultimate completion date of August 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...